)--Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry for the development of stem cell technologies for regenerative medicine, today announced that they have developed a novel pharmacological Inhibitor CEP1430 synthetic ...
http://ift.tt/1JIXrbd
http://ift.tt/1JIXrbd
No comments:
Post a Comment